ITD
DEAD

Serial Number

76354479

Owner

MEDIGENE AG

Attorney

ADRIENNE L. WHITE, ESQUIRE

Filing Date

Jan 3, 2002

Add to watchlist:

No watchlists yet
View on USPTO

ITD Trademark

Serial Number: 76354479

ITD is a trademark filed by MEDIGENE AG on January 3, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

MEDIGENE AG (25 trademarks)

Lochhamer Strasse 11
MARTINSRIED, MUNICH , DE

Entity Type: 03

Trademark Details

Filing Date

January 3, 2002

Registration Date

Not Registered

Goods & Services

MEDICINES, SERUMS, AND THERAPEUTIC PREPARATIONS FOR HUMANS AND ANIMALS, MANUFACTURED USING THE IDENTIFICATION, ANALYSIS AND VALIDATION OF TARGET GENES, FOR THE TREATMENT OF CARDIAC DISEASES, SKIN DISEASES, CANCER, DIABETES AND OBESITY; TEST KITS FOR CLINICAL AND MEDICAL LABORATORY USE, MANUFACTURED USING THE IDENTIFICATION, ANALYSIS AND VALIDATION OF TARGET GENES, COMPRISED OF BIOCHEMICAL AND BIOTECHNOLOGICAL COMPONENTS FOR THE IDENTIFICATION, ANALYSIS AND VALIDATION OF TARGET GENES AND/OR THE IDENTIFICATION OF NEW PHARMACEUTICALLY ACTIVE COMPOUNDS FOR HUMAN MEDICAL AND VETERINARY MEDICAL DIAGNOSTIC AND THERAPY PURPOSES; AND DIAGNOSTIC PREPARATIONS FOR CLINICAL AND MEDICAL LABORATORY USE MANUFACTURED USING THE IDENTIFICATION ANALYSIS AND VALIDATION OF TARGET GENES

TEST KITS FOR SCIENTIFIC AND RESEARCH USE, MANUFACTURED USING THE IDENTIFICATION, ANALYSIS AND VALIDATION OF TARGET GENES, COMPRISED OF BIOCHEMICAL AND BIOTECHNOLOGICAL COMPONENTS FOR THE IDENTIFICATION, ANALYSIS AND VALIDATION OF TARGET GENES AND/OR THE IDENTIFICATION OF NEW PHARMACEUTICALLY ACTIVE COMPOUNDS FOR HUMAN MEDICAL AND VETERINARY MEDICAL DIAGNOSTIC AND THERAPY PURPOSES; AND DIAGNOSTIC PREPARATIONS FOR SCIENTIFIC AND RESEARCH USE MANUFACTURED USING THE IDENTIFICATION, ANALYSIS AND VALIDATION OF TARGET GENES

MOLECULAR BIOLOGY SERVICES, NAMELY, SCIENTIFIC RESEARCH AND DEVELOPMENT IN THE FIELD OF IDENTIFICATION, ANALYSIS AND VALIDATION OF TARGET GENES FOR THE DEVELOPMENT OF NEW PHARMACEUTICALLY ACTIVE COMPOUNDS FOR HUMANS MEDICAL AND VETERINARY MEDICAL DIAGNOSTIC AND THERAPEUTIC PURPOSES

Filing History

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 21, 2003 ABN2
FINAL REFUSAL MAILED
Nov 7, 2002 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 26, 2002 CRFA
PAPER RECEIVED
Sep 26, 2002 MAIL
NON-FINAL ACTION MAILED
Mar 26, 2002 CNRT
ASSIGNED TO EXAMINER
Mar 20, 2002 DOCK